Form D — Commense Bio, Inc.

0002135129-26-000001 · filed Jun 12, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $2,671,875
Reported amount sold: $2,470,334
Minimum investment: $0
Investors: 31
Sales commission: $0
Finders' fees: $0

Issuer

Name: Commense Bio, Inc.
CIK: 2135129
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 2805 WILDERNESS PLACE, SUITE 1000
BOULDER, CO 80301
Phone: (720) 755-5807

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Erik Prentice · Director

Boulder, CO Find on LinkedIn ↗
N. Stuart Harris · Director

Boulder, CO Find on LinkedIn ↗
Joshua Smith · Director

Boulder, CO Find on LinkedIn ↗
Judith Boice · Director

Boulder, CO Find on LinkedIn ↗
Todd Turner · Executive Officer

Boulder, CO Find on LinkedIn ↗
Randall W. Viola · Director

Boulder, CO Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗